The effect of pms50 supplement on the psychological symptoms of premenstrual syndrom

The effect of pms50 supplement on the psychological symptoms of girls with premenstrual syndrome

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181218042038N1

Enrollment

Registered

2019-01-15

Start date

2018-12-22

Completion date

Unknown

Last updated

2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychological symptoms of premenstrual syndrome. Premenstrual tension syndrome

Interventions

Intervention 1: Intervention group: Supplement pms50 containing vitamins B1, B2, B6, E, D3, magnesium oxide and Vitagnus extract, two daily pills (one morning and one night) from one week before menst

Eligibility

Sex/Gender

Female

Age

25 Years to 35 Years

Inclusion criteria

Inclusion criteria: Unmarried Premenstrual syndrome Regular menstrual cycle Age range 25-35 Weight range 55-65kg Normal BMI ranging from18.5 to 24.9 kg/m2

Exclusion criteria

Exclusion criteria: Being married Pregnancy Lactation Irregular menstrual cycle Age younger than 25 or over 35 years old Weight below 55 or above 65kg Use of psychological drugs Unwillingness of the participant to continue the research

Design outcomes

Primary

Measure	Time frame
Anger Score in the Rossignol & Bonlander Questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;Irritability score in the Russugnol and Bonlander questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;Anxiety score in the Rossignol & Bonlander Questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;Transient mood Score in the Rossignol & Bonlander Questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;Feeling frustrated score in the Rossignol & Bonlander Questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;Loneliness and isolation score in the Russugnol and Bonlander Questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;The score for the lack of attractiveness in the Russugnol and Bonlander questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;Increased or decreased appetite score in the Russugnol and Bonlander questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;Score the tendency to salty or sweet foods in the Russugnol and Bonlander questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;Restlessness score in the Rossignol & Bonlander Questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;Depression score in the Russugnol and Bonlander questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.	—

Measure

Time frame

Anger Score in the Rossignol & Bonlander Questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;Irritability score in the Russugnol and Bonlander questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;Anxiety score in the Rossignol & Bonlander Questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;Transient mood Score in the Rossignol & Bonlander Questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;Feeling frustrated score in the Rossignol & Bonlander Questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;Loneliness and isolation score in the Russugnol and Bonlander Questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;The score for the lack of attractiveness in the Russugnol and Bonlander questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;Increased or decreased appetite score in the Russugnol and Bonlander questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;Score the tendency to salty or sweet foods in the Russugnol and Bonlander questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;Restlessness score in the Rossignol & Bonlander Questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.;Depression score in the Russugnol and Bonlander questionnaire. Timepoint: The beginning and the end of the study. Method of measurement: Rossignol & Bonlander Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh sadeghi

Ahvaz University of Medical Sciences

sadeghi.f@ajums.ac.ir+98 61 7333 8383

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026